Return
Infectious complications of CD19-targeted chimeric antigen receptor T-cell therapy: a multicenter cohort study
J
J
J
J
A
I
R
M
M
J
F
N
M
A
N
P
D
E
E
C
T
M
Y
M
T
DOI:10.1093/ofid/ofag423.png)
Abstract
En 中文
Our understanding of the epidemiology of and risk factors for post-chimeric antigen receptor T-cell therapy (CART) infections is largely based on data from single-center studies with small sample sizes.
Journal
IF:
3.8
Papers:
6.3K
Citations:
1.4W
